U.S. market Closed. Opens in 10 hours 41 minutes

BIOSW | BioPlus Acquisition Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312018-12-312017-12-312016-12-31
RevenueN/AN/A708.90M817.20M935.60M
Cost of Revenue1.17MN/A465.90M547.90M670.00M
Gross Profit-1.17MN/A243.00M269.30M265.60M
Operating Expenses1.17M162.00236.90M284.10M263.70M
Selling, General & Admin1.17K162.0047.30M63.30M66.00M
Research & DevelopmentN/AN/AN/AN/AN/A
Other Operating Expenses1.17MN/A189.60M220.80M197.70M
Operating Income-1.17M-162.00-108.50M-52.70M-77.70M
Other Expenses / Income3.17M9.0057.50M-14.70M45.30M
Before Tax Income2.00M-152.00-51.00M-67.40M-32.40M
Income Tax Expenses-3.17M9.00600.00K63.60M2.00M
Net Income5.16M-152.00-51.60M-131.00M-34.40M
Interest Expenses-3.17MN/A-57.40M-52.10M-38.20M
Basic Shares Outstanding597.79M6.88K127.90M123.80M93.70M
Diluted Shares Outstanding597.79M6.88K127.90M123.80M93.70M
EBITDA-1.17M9.00-84.90M-24.97M-56.15M
EBITDA Margin0.00%0.00%-11.98%-3.06%-6.00%
EBIT-1.17M-143.00-108.40M-119.50M-70.60M
EBIT Margin0.00%0.00%-15.29%-14.62%-7.55%
Financial Year End2022-12-312021-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙